Elanco Animal Health Inc (ELAN)

Sentiment-Signal

20,5
Stark Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
45.7
1 neu, 0 erhöht, -8307109K $ netto
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)

Score-Verlauf (90 Tage)

Kritische 8-K Meldungen

DatumMeldungSchwereFilingAuszug
28.05.2025Item 5.02 — Abgang SchlüsselpersonenHOCHSEC        Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Co
17.03.2025Item 5.02 — Abgang SchlüsselpersonenHOCHSEC        Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Co
12.11.2024Item 5.02 — Abgang SchlüsselpersonenHOCHSEC        Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Co
01.04.2024Item 5.02 — Abgang SchlüsselpersonenHOCHSECcorporated herein by reference.    Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointm
22.05.2023Item 5.02 — Abgang SchlüsselpersonenHOCHSEC      Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Comp

Stammdaten

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

Unternehmen & Branche

NameElanco Animal Health Inc
TickerELAN
CIK0001739104
BoerseUS
SektorHealthcare
IndustrieDrug Manufacturers - Specialty & Generic
SIC2834 · Pharmaceutical Preparations

Wertpapier & Kennzahlen

CUSIP28413U204
ISINUS28413U2042
TypCommon Stock
Marktkapitalisierung10,91 Mrd. USD
Beta1,88
Dividendenrendite0,00 %

Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »

Finanzkennzahlen (SEC XBRL)

PeriodeFilingUmsatzNettoergebnisEPSAktivaEigenkapital
2025-12-3110-K4,715,000,000-232,000,000-0.4713,358,000,0006,547,000,000
2025-09-3010-Q1,137,000,000-34,000,000-0.0713,551,000,0006,749,000,000
2025-06-3010-Q1,241,000,00011,000,0000.0213,742,000,0006,775,000,000
2025-03-3110-Q1,193,000,00067,000,0000.1312,941,000,0006,353,000,000
2024-12-3110-K4,439,000,000338,000,0000.6812,614,000,0006,096,000,000
2024-09-3010-Q1,030,000,000364,000,0000.7313,283,000,0006,523,000,000
2024-06-3010-Q1,184,000,000-50,000,000-0.1013,764,000,0005,942,000,000
2024-03-3110-Q1,205,000,00032,000,0000.0614,019,000,0006,056,000,000
2023-12-3110-K4,417,000,000-1,231,000,000-2.5014,362,000,0006,223,000,000
2023-09-3010-Q1,068,000,000-1,096,000,000-2.2214,344,000,0006,134,000,000
2023-06-3010-Q1,057,000,000-97,000,000-0.2015,796,000,0007,420,000,000
2023-03-3110-Q1,257,000,000103,000,0000.2115,769,000,0007,480,000,000
2022-12-3110-K4,411,000,000-78,000,000-0.1615,491,000,0007,289,000,000
2022-09-3010-Q1,026,000,000-65,000,000-0.1314,948,000,0006,714,000,000
2022-09-3010-K-65,000,000-0.13
2022-06-3010-Q1,175,000,000-10,000,000-0.0215,601,000,0007,125,000,000
2022-06-3010-K-10,000,000-0.02
2022-03-3110-K51,000,0000.10
2022-03-3110-Q1,226,000,00051,000,0000.1016,251,000,0007,585,000,000
2021-12-3110-K4,764,000,000-105,000,000-0.2216,478,000,0007,508,000,000

Fondsaktivität (Vorquartalsvergleich)

FondsAktuell (Stk)Vorquartal (Stk)Veränderung (Stk)Wert (USD)StatusΔTrend
FMR LLC52,196,321052,196,3211,181,202,754Neu+100,0%
VANGUARD GROUP INC48,059,731048,059,7311,087,591,712Neu+100,0%
BlackRock, Inc.46,335,397046,335,3971,048,570,038Neu+100,0%
PRIMECAP MANAGEMENT CO/CA/46,214,088046,214,0881,045,824,811Neu+100,0%
DIMENSIONAL FUND ADVISORS LP25,082,545025,082,545567,621,557Neu+100,0%
STATE STREET CORP15,050,538015,050,538340,593,675Neu+100,0%
GEODE CAPITAL MANAGEMENT, LLC9,425,53309,425,533213,342,792Neu+100,0%
UBS Group AG8,677,84408,677,844196,379,609Neu+100,0%
MILLENNIUM MANAGEMENT LLC8,586,70708,586,707194,317,179Neu+100,0%
MORGAN STANLEY8,286,60808,286,608187,525,955Neu+100,0%
MANUFACTURERS LIFE INSURANCE COMPANY, THE7,263,16207,263,162164,369,893Neu+100,0%
Clearbridge Investments, LLC5,672,64505,672,645128,371,956Neu+100,0%
Invesco Ltd.4,789,03704,789,037108,375,907Neu+100,0%
BARROW HANLEY MEWHINNEY & STRAUSS LLC4,313,08604,313,08697,605,136Neu+100,0%
BRANDES INVESTMENT PARTNERS, LP4,201,86404,201,86495,088,183Neu+100,0%
NORTHERN TRUST CORP4,108,90804,108,90892,984,588Neu+100,0%
CITADEL ADVISORS LLC3,917,32603,917,32688,649,088Neu+100,0%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC3,540,72803,540,72880,126,668Neu+100,0%
Douglas Lane & Associates, LLC3,048,09203,048,09268,978,328Neu+100,0%
JENNISON ASSOCIATES LLC2,626,44902,626,44959,436,541Neu+100,0%
Artemis Investment Management LLP2,461,01802,461,01855,692,837Neu+100,0%
BANK OF AMERICA CORP /DE/2,434,18302,434,18355,085,562Neu+100,0%
BNP PARIBAS FINANCIAL MARKETS2,252,96102,252,96150,984,507Neu+100,0%
Capital World Investors2,078,88802,078,88847,045,235Neu+100,0%
Quantinno Capital Management LP1,833,96801,833,96841,502,715Neu+100,0%
JPMORGAN CHASE & CO1,814,14301,814,14341,054,077Neu+100,0%
BlackBarn Capital Partners LP1,700,00001,700,00038,471,000Neu+100,0%
GOLDMAN SACHS GROUP INC1,587,70901,587,70935,929,862Neu+100,0%
Redwood Grove Capital, LLC1,557,00001,557,00035,234,910Neu+100,0%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC1,520,37101,520,37134,405,995Neu+100,0%
NORGES BANK1,432,39401,432,39432,415,076Neu+100,0%
RAYMOND JAMES FINANCIAL INC1,402,44401,402,44431,737,304Neu+100,0%
WELLINGTON MANAGEMENT GROUP LLP1,390,84501,390,84531,474,823Neu+100,0%
PRINCIPAL FINANCIAL GROUP INC1,292,23601,292,23629,243,301Neu+100,0%
PRIVATE MANAGEMENT GROUP INC1,281,07401,281,07428,990,705Neu+100,0%
RHUMBLINE ADVISERS1,243,68401,243,68428,144,518Neu+100,0%
Swiss National Bank979,5920979,59222,168,167Neu+100,0%
DDD Partners, LLC927,0180927,01820,978,417Neu+100,0%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM866,0970866,09719,599,775Neu+100,0%
Legal & General Group Plc781,2310781,23117,679,260Neu+100,0%
ExodusPoint Capital Management, LP763,3310763,33117,274,181Neu+100,0%
DAVIDSON INVESTMENT ADVISORS680,8670680,86715,408,020Neu+100,0%
SEI INVESTMENTS CO674,6720674,67215,267,909Neu+100,0%
PICTON MAHONEY ASSET MANAGEMENT671,0630671,06315,186,156Neu+100,0%
ALLIANCEBERNSTEIN L.P.635,1550635,15514,373,558Neu+100,0%
Hardman Johnston Global Advisors LLC630,8400630,84014,275,909Neu+100,0%
AMERIPRISE FINANCIAL INC622,4500622,45014,086,056Neu+100,0%
Weiss Asset Management LP580,9430580,94313,146,740Neu+100,0%
Old West Investment Management, LLC499,3480499,34811,300,245Neu+100,0%
ROYCE & ASSOCIATES LP494,9260494,92611,200,175Neu+100,0%

Insider-Transaktionen (12 Monate)

DatumInsiderRolleTypStückzahlKursWert (USD)ΔTrend
2025-12-12Kurzius Lawrence ErikDirectorOpen Market Purchase10,00021.30213,000.00+90,8%
2025-12-11VanHimbergen Robert MOfficer, EVP and CFOOpen Market Purchase6,95021.64150,426.50+64,2%
2025-12-11Simmons Jeffrey NDirector, Officer, PRESIDENT, CEO AND DIRECTOROpen Market Purchase22,00021.75478,495.60+204,1%
2025-12-11Modi Rajeev A.Officer, SEE REMARKSOpen Market Purchase4,50021.3395,985.00+40,9%

Top-Fondshalter

Stand: 31.03.2026

FondsAnteileWert (USD)Anteil (%)
OPPENHEIMER & CO INC8,973214,724100.00

Hinweis

Erweitert ×